Patent ID: 8735429

Claim:
A method of treating cancer in a warm-blooded animal, including man, in need of such treatment which comprises administering to said animal an HDAC1inhibitory effective amount of a compound of formula (IA): wherein R 2 , R 3 and R 5 are each independently selected from hydrogen or methyl; or a pharmaceutically acceptable salt thereof; and wherein the cancer is selected from the group consisting of oesophageal cancer, myeloma, hepatocellular, pancreatic and cervical cancer, Ewings tumour, neuroblastoma, kaposis sarcoma, ovarian cancer, breast cancer, colorectal cancer, prostate cancer, bladder cancer, melanoma, lung cancer [including non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)], gastric cancer, head and neck cancer, brain cancer, renal cancer, lymphoma and leukaemia.